Who Owns Your Doctor? Private Equity and Southern Oregon Healthcare, Part 1 of 4
There are five physical therapy clinics operating in Medford and Grants Pass right now that most people in this region have never heard of — not as clinics, but as investments. They operate under the name BenchMark Physical Therapy. They have staff, schedules, waiting rooms, and billing offices. The therapists who work there are trained professionals doing their jobs. But the entity that owns those clinics is not a physical therapist or a local business group or even an Oregon company. It is Revelstoke Capital Partners, a private equity firm headquartered in Denver, Colorado, operating through a holding company called Upstream Rehabilitation based in Birmingham, Alabama.
When a Southern Oregon resident pays a copay at a BenchMark clinic, or when AllCare processes a reimbursement for a Medicaid patient’s session, a portion of that revenue — after operating costs are covered — does not stay in the Rogue Valley. It does not pay the salary of a Medford accountant or a Grants Pass building manager. It does not generate a donation to the Rogue Valley Community Foundation or a Jackson County property tax contribution. It travels to Birmingham and then to Denver, where it services debt and generates returns for investors who have never been to Southern Oregon and have no financial stake in whether its residents can get physical therapy appointments.
Most people in this region know, in a general way, that private equity is not a community institution. What most people don’t understand is the specific mechanism by which it works, why that mechanism is particularly damaging in healthcare, and why Southern Oregon — with its documented provider shortage, its aging independent practitioner cohort, and its limited economic alternatives — is exactly the kind of market that private equity targets next.
This article explains the mechanism. The rest of this series examines the evidence, the distinctions that matter, and what Southern Oregon can do about it.
How Private Equity Actually Works
Private equity is not a type of business. It is a type of ownership structure — specifically, a structure designed to generate large financial returns over a short time period by acquiring, restructuring, and reselling businesses.
Here is how the standard transaction works.
A PE firm raises a fund by collecting money from outside investors. Those investors are typically pension funds, university endowments, sovereign wealth funds, and very wealthy individuals. The PE firm charges those investors a management fee — typically 2% of committed capital per year — and a performance fee called “carried interest” — typically 20% of profits above a threshold return. The PE firm then uses that pooled capital to acquire businesses.
The acquisition itself is where the mechanism gets consequential. When a PE firm buys a business, it typically puts up only 20 to 40 percent of the purchase price from the fund. The remaining 60 to 80 percent is borrowed — but that debt is not the PE firm’s liability. It is loaded directly onto the acquired business. The business that was just purchased is now responsible for paying back the loan that was used to buy it. This is called a leveraged buyout, and it is the foundational transaction of the private equity industry.
The practical effect: the acquired business, from the day of purchase, is servicing debt it did not choose and did not benefit from. Cash flow that might otherwise go to staff raises, equipment upgrades, facility improvements, or expanded services instead goes to interest payments on acquisition debt. Meanwhile, the PE firm controls an asset worth far more than what it actually invested — its equity stake is amplified, its returns are multiplied.
The exit is everything. PE firms plan to sell their investments within three to seven years. The return on that investment depends on whether the business is worth more at sale than at acquisition — and whether the appearance of value can be maintained long enough to complete the sale, even when the underlying business has been degraded by debt service and cost-cutting. When PE ownership works as advertised, the business genuinely improves and the community benefits. When it doesn’t — which the data shows happens at much higher rates than in businesses not subject to leveraged buyouts — the business goes bankrupt, staff lose jobs, and patients lose access to care.
There is one more piece of the mechanism that Southern Oregon residents paying taxes should understand. PE firm managers pay capital gains tax rates — currently 20 percent — on their carried interest earnings, rather than ordinary income tax rates, which reach 37 percent. A PE partner earning ten million dollars in carried interest pays the same tax rate as someone earning forty thousand dollars in stock market gains. A nurse practitioner in Medford earning one hundred and thirty thousand dollars pays a higher marginal rate than that PE partner. This differential is not a technicality. It is a federal subsidy of the private equity industry, estimated at fourteen billion dollars per year, built into the tax code and defended by the industry’s lobbying operation against reform efforts in every recent Congress.
Why Healthcare Became a Target
Private equity has always targeted industries with reliable cash flow, fragmented ownership, and limited competition from other buyers. Healthcare has all three, plus a fourth characteristic that makes it especially attractive: the patients cannot easily stop consuming it.
When a PE firm buys a manufacturing company and extracts value through cost-cutting, customers who don’t like the product can switch to a competitor. When a PE firm buys a dental practice in a market with limited competition, patients who need a root canal do not have an easy alternative. The inelasticity of healthcare demand — the fact that people need care regardless of quality or price — insulates PE-owned healthcare businesses from the market discipline that normally constrains extraction.
The acquisition wave in healthcare accelerated after the 2008 financial crisis, when low interest rates made leveraged buyouts cheap and large institutional investors were searching for returns in a low-yield environment. Between 2010 and 2023, PE acquisitions in healthcare grew from fewer than 500 transactions per year to more than 1,000. In 2024, dental care alone saw 161 PE-related transactions — a ten percent increase from the prior year. Between 2015 and 2021, the share of dental practices affiliated with PE-backed Dental Service Organizations nearly doubled, from 6.6 percent to 12.8 percent. Physical therapy followed a similar trajectory.
The sectors that PE targeted first were those with high volume, relatively standardized procedures, and limited regulatory oversight: dental, dermatology, ophthalmology, physical therapy, behavioral health, and gastroenterology. These are not coincidentally the specialties where Southern Oregon already faces significant access shortages.
The Management Services Organization and Oregon’s Response
Most states, including Oregon, have laws on the books that technically prohibit corporations and non-physician investors from owning medical practices. These are called Corporate Practice of Medicine statutes, and they were designed to ensure that clinical decisions remain in the hands of licensed practitioners rather than business executives focused on quarterly returns.
Private equity found a workaround decades ago. The Management Services Organization, or MSO, is a separately owned entity that handles all non-clinical functions: billing, HR, scheduling, facilities, compliance, contracting, and real estate. Technically, the physicians or clinicians still “own” the practice. In practice, the MSO controls everything that determines how the practice operates — and often includes contractual provisions that prevent clinicians from selling their equity to anyone other than the MSO-controlling entity.
Oregon’s legislature passed Senate Bill 951 in June 2025, which takes effect for new investments beginning January 2026 and requires existing arrangements to come into compliance by January 2029. Law firms analyzing the legislation called it the toughest state barrier to private equity in healthcare in the country. SB 951 closes the MSO loophole for physician practices in Oregon, limits noncompete agreements, and creates new transparency requirements for healthcare ownership transactions.
There is a significant gap in SB 951 that matters directly to Southern Oregon residents. The law explicitly does not apply to dental practices, physical therapy, occupational therapy, or most behavioral health practices. The sectors where private equity has been most aggressively acquiring in this region — BenchMark Physical Therapy is already here, and Dental Service Organization expansion is accelerating nationally — are the sectors Oregon’s landmark law does not cover. The implications of that gap are the subject of the final article in this series.
The Ownership Spectrum: What Actually Operates in Southern Oregon
Not all outside ownership is the same, and the distinctions matter for where money goes and who makes decisions. Here is the honest spectrum, from most to least locally beneficial, with Southern Oregon examples.
At the most local end is the independent clinician-owned single practice: a dentist who trained here, owns the building, employs local staff, and whose financial life is tied entirely to this community. When that practice is profitable, the money stays in Southern Oregon. When it faces financial pressure, the owner has every incentive to work through it rather than extract and exit.
The next level is the clinician-owned multi-location group. Therapeutic Associates Physical Therapy, which operates in Southern Oregon and acquired practices including Medford Sports Injury and Therapy Center in 2022, describes itself as one of the largest physical therapist-owned and operated companies in the country, founded in 1952. Profits in this model stay within a clinician-ownership structure. The owners are physical therapists, not investment managers. The exit horizon is not three to seven years — it is a career.
Further along the spectrum is the corporate chain that is not PE-backed: a regional dental group or PT brand where a local franchise owner or clinic director has real equity and real decision-making authority, paying royalties or management fees to a distant headquarters but retaining meaningful local ownership. Open Door Family Dentistry, founded in Medford in 2015 and apparently independently capitalized, appears to occupy this or the first category — though direct verification is recommended.
Then comes the PE-backed chain with local clinician minority equity — the BenchMark/Upstream/Revelstoke model. Clinicians may hold small equity stakes in their individual clinics, but the majority equity and all strategic decisions flow to the PE fund. Debt service on the leveraged acquisition comes first. Local reinvestment comes last.
At the far end is the full corporate acquisition with no local equity — the Optum model, which acquired Oregon Medical Group in Eugene and the Corvallis Clinic in 2024. No local ownership stake, corporate management from a national headquarters, clinical decisions subordinated to productivity quotas and system-wide protocols.
The Local Economy Argument
The most important thing for Southern Oregon residents to understand about private equity in local healthcare is not primarily about care quality, though quality effects are real and documented. It is about the local economy.
Research on local economic multipliers consistently finds that each dollar spent at a locally owned business generates two to six additional dollars of economic activity in the surrounding community, because locally owned businesses are more likely to pay wages to local employees, purchase goods from other local businesses, pay rent to local property owners, and contribute to local charitable organizations. That multiplier effect is the engine of local economic health.
When a Southern Oregon resident’s physical therapy payment flows through BenchMark to Upstream to Revelstoke Capital Partners in Denver, the local multiplier on the PE-extracted portion of that revenue approaches zero. That money is not hiring a Medford bookkeeper. It is not paying dues at the Rogue Valley Chamber of Commerce. It is not funding a scholarship at Southern Oregon University. It is servicing acquisition debt and generating returns for pension fund managers in New York or sovereign wealth investors in Abu Dhabi.
For a region that is already fighting to retain healthcare providers, keep housing affordable for clinical staff, and build the kind of institutional infrastructure that can address a documented primary care shortage, subsidizing the return requirements of a Denver PE fund with local healthcare revenue is not a neutral economic fact. It is a structural drain on the community’s capacity to solve its own problems.
The BenchMark/Upstream ownership chain in Southern Oregon is not unique or unusual. It is the current standard operating model for PE-backed healthcare. It is in this region now. And the sectors where Oregon’s new law offers no protection — dental and physical therapy — are the sectors where the acquisition wave is still accelerating.
The rest of this series examines what the evidence shows happens when the wave arrives in full, what distinguishes better and worse forms of outside ownership, and what Southern Oregon residents and institutions can do to shape what comes next.
This is the first article in a four-part series on private equity and healthcare in Southern Oregon. Part 2 examines the evidence from PE-owned practices and the Oregon Medical Group story. Part 3 addresses the distinctions between private equity, franchises, and clinician-owned chains — and what they mean for the local economy. Part 4 covers Oregon’s new law, its gaps, and what Southern Oregon can do. We publish research and analysis on healthcare system design in Southern Oregon. We welcome responses, corrections, and partnership inquiries at reimagine-healthcare.org.